KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $52.0 million.

  • Oscar Health's Other Non-Current Liabilities fell 1515.62% to $52.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $52.0 million, marking a year-over-year decrease of 1515.62%. This contributed to the annual value of $52.0 million for FY2025, which is 1515.62% down from last year.
  • As of Q4 2025, Oscar Health's Other Non-Current Liabilities stood at $52.0 million, which was down 1515.62% from $55.8 million recorded in Q3 2025.
  • Oscar Health's Other Non-Current Liabilities' 5-year high stood at $77.1 million during Q1 2022, with a 5-year trough of $52.0 million in Q4 2025.
  • Over the past 5 years, Oscar Health's median Other Non-Current Liabilities value was $67.6 million (recorded in 2023), while the average stood at $66.6 million.
  • In the last 5 years, Oscar Health's Other Non-Current Liabilities skyrocketed by 41208.93% in 2021 and then crashed by 1515.62% in 2025.
  • Oscar Health's Other Non-Current Liabilities (Quarter) stood at $76.8 million in 2021, then fell by 5.93% to $72.3 million in 2022, then fell by 6.51% to $67.6 million in 2023, then decreased by 9.31% to $61.3 million in 2024, then decreased by 15.16% to $52.0 million in 2025.
  • Its last three reported values are $52.0 million in Q4 2025, $55.8 million for Q3 2025, and $57.3 million during Q2 2025.